✨ Free AI Report
Akoya Biosciences, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Akoya Biosciences, Inc.
Company Research

Akoya Biosciences, Inc.: Business Overview, Financials & Competitive Analysis

Akoya Biosciences, Inc. scores 5/10 on the AskCyborg Cyborg Score (Mixed). Strong technology platform in growing spatial biology market, but profitability challenged; recent acquisition by Quanterix provides resources for scaling. The company generates gross profit of $47.9M but operates with negative operating income of -$46.7M on a TTM basis, indicating profitability challenges despite revenue generation. Recent acquisition by Quanterix provides.

What is Akoya Biosciences, Inc.'s industry? Akoya Biosciences, Inc. (akoyabio.com) operates in Life Sciences Technology / Spatial Biology / Biotechnology Research. AskCyborg classifies Akoya Biosciences, Inc. under Life Sciences Technology / Spatial Biology / Biotechnology Research in its company registry.

Akoya Biosciences is a life sciences technology company providing spatial biology solutions for transforming discovery, clinical research, and diagnostics globally. The company offers two industry-leading platforms: t...

5/ 10Mixed

Cyborg Score thesis

Strong technology platform in growing spatial biology market, but profitability challenged; recent acquisition by Quanterix...

Read the full analyst-debate transcript →
Industry Life Sciences Technology / Spatial Biology / Biotechnology Research
2 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Akoya Biosciences, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Akoya Biosciences, Inc.

AskCyborg analysts argue the bull and bear cases for Akoya Biosciences, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Akoya Biosciences, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Akoya Biosciences, Inc. Overview

Pro stress-test →

Akoya Biosciences is a life sciences technology company providing spatial biology solutions for transforming discovery, clinical research, and diagnostics globally. The company offers two industry-leading platforms: the CODEX system for quantifying more than 40 biomarkers and the Phenoptics platform for multiplexed immunofluorescence solutions.

Strategic Profile

Pro stress-test →

As of July 8, 2025, Akoya Biosciences operates as a subsidiary of Quanterix Corporation, which strengthens its market position and resources. The company is positioned in the high-growth spatial biology market, targeting immuno-oncology and translational research applications with a diverse product portfolio and advanced imaging solutions.

Competitive Landscape

Pro stress-test →

Akoya competes in the spatial biology and tissue imaging market against companies offering similar high-parameter tissue analysis solutions. The company's platforms empower researchers to understand complex diseases such as cancer and autoimmune or neurological disorders, positioning it in the precision medicine segment where competition includes other imaging and biomarker analysis vendors.

Industry Context

Akoya Biosciences, Inc. operates in Life Sciences Technology / Spatial Biology / Biotechnology Research.

Key facts

Founded: 2015 · Headquarters: Marlborough, Massachusetts, US · Employees: 201 · Revenue: $47.9M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Akoya Biosciences, Inc..

  • Spatial biology is an emerging market with strong biotech and pharma demand for multi-parameter tissue analysis
  • Acquisition by Quanterix for nearly $364 million validates market positioning and provides capital for growth
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • July 2025Akoya became a subsidiary of Quanterix Corporation
  • 2024-2025Scott Mendel appointed as new Chairman of the Board, effective October 2, 2024
  • +1 moreTrack every material event for Akoya Biosciences, Inc. as it happens. Explore monitoring →
Get alerted when Akoya Biosciences, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Ultra-sensitive Biomarker DetectionComplementary biomarker detection technology→Multiplexed ImmunofluorescenceCompeting spatial imaging solutions→

Compare Akoya Biosciences, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Akoya Biosciences, Inc. operates in Life Sciences Technology / Spatial Biology / Biotechnology Research. See how the rest of the sector scores on the Cyborg framework.

Browse Life Sciences Technology / Spatial Biology / Biotechnology Research research →
NEW · MCP server

Ask your AI assistant about Akoya Biosciences, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Akoya Biosciences, Inc. and its top competitor on Cyborg Score”
“What did Akoya Biosciences, Inc. do this quarter?”
“Is Akoya Biosciences, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Akoya Biosciences, Inc. do?+
Akoya Biosciences is a life sciences technology company providing spatial biology solutions for transforming discovery, clinical research, and diagnostics globally. The company offers two industry-leading platforms: t...
What is Akoya Biosciences, Inc.'s Cyborg Score?+
Akoya Biosciences, Inc. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Akoya Biosciences, Inc.'s main competitors?+
Named competitors include Ultra-sensitive Biomarker Detection, Multiplexed Immunofluorescence. The full competitive landscape is in the AskCyborg report.
How can I get the full Akoya Biosciences, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Akoya Biosciences, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Akoya Biosciences, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Life Sciences Technology research

Companies in the same sector and named competitors, ranked by Cyborg Score.

4Rapid Micro Biosystems, Inc.